1969
DOI: 10.1016/s0022-5223(19)42577-4
|View full text |Cite
|
Sign up to set email alerts
|

Carcinoma of the esophagus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

1978
1978
1984
1984

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…Carcinoma of the upper third of the esophagus, the segment situated below the suprasternal notch and above the aortic arch, is being treated with radiotherapy in most patients, for this carcinoma has Presented at the XXVIIth Congress of the Soci6t6 Internationale de Chirurgie, Kyoto, Japan, September [3][4][5][6][7][8]1977.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Carcinoma of the upper third of the esophagus, the segment situated below the suprasternal notch and above the aortic arch, is being treated with radiotherapy in most patients, for this carcinoma has Presented at the XXVIIth Congress of the Soci6t6 Internationale de Chirurgie, Kyoto, Japan, September [3][4][5][6][7][8]1977.…”
mentioning
confidence: 99%
“…There was no 5-year survival. Lawler et al [4] subjected 6 patients to surgical extirpation with 3 surviving 1 year; of 22 patients who were irradiated, there was one 5-year survival. Because of the poor results of surgical management of such patients, radiotherapy has become the treatment of choice.…”
mentioning
confidence: 99%
“…Patients with resectable carcinoma of the thoracic esophagus have been rather infrequent, and the operative mortality rate has been high. In the series of Lawler et al [7] the resectability rate was 34% and the operative mortality rate was 32%. Younghusband and Aluwihare reported a resectability rate of 47% and an operative mortality rate of 16% [8].…”
Section: Discussionmentioning
confidence: 90%
“…The long-term survival rate after radical operation for esophageal carcinoma has been very low until recently. Reported 5-year survival rates have usually ranged from 0 to 15% [1,7,11]. In 1,586 patients collected by Sato [13], the 5-year survival rate was 14.0%.…”
Section: More Thanmentioning
confidence: 99%
See 1 more Smart Citation